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Abstract
Introduction: Circadian rhythms play an important role in the body and in single cells. Rhythms of molecular
clocks have not been investigated in synovial fibroblasts (SF) of patients with osteoarthritis (OA) and rheumatoid
arthritis (RA). The study was initiated to fill this gap and to study effects of interleukin (IL)-1b/tumor necrosis factor
(TNF) on rhythmicity in synovial fibroblasts of RA and OA patients.
Methods: The presence of BMAL-1, CLOCK, Period 1 and Period 2 proteins in synovial tissue was investigated by
immunofluorescence. The presence of mRNA of molecular clocks was studied during 72 h by qPCR. Characteristics
of rhythms were studied with time series analysis.
Results: BMAL-1, CLOCK, Period 1 and Period 2 proteins were abundantly present in synovial tissue of OA, RA
and controls. Receiving synovial tissue at different operation time points during the day (8:00 am to 4:00 pm)
did not reveal a rhythm of BMAL-1 or Period 1 protein. In OASF and RASF, no typical rhythm curve of molecular
clock mRNA was observed. Time series analysis identified a first peak between 2 and 18 hours after
synchronization but a period was not detectable due to loss of rhythm. TNF inhibited mRNA of CLOCK, Period 1
and Period 2 in OASF, while IL-1b and TNF increased these factors in RASF. This was supported by dose-
dependently increased levels in MH7A RA fibroblasts. In RASF, IL-1b and TNF shifted the first peak of BMAL-1
mRNA to later time points (8 h to 14 h).
Conclusion: Rhythmicity is not present in primary OASF and RASF, which is unexpected because fibroblasts usually
demonstrate perfect rhythms during several days. This might lead to uncoupling of important cellular pathways.
Introduction
Symptoms, such as swelling, pain, stiffness, and func-
tional ability, follow a circadian rhythm in patients with
rheumatoid arthritis (RA) [1]. The circadian change of
symptoms depends on increased levels of proinflamma-
tory cytokines in the late night and early morning [1-4],
which can be blocked by night time application of glu-
cocorticoids [4-6]. Circadian changes on the level of the
entire body might be translated into rhythmic phenom-
ena in peripheral cells of inflamed tissue. While
oscillations of the entire system are dependent on exter-
nal synchronizers, such as light, and are called circadian
rhythms, undulations of intracellular molecular clock
networks are dubbed daily rhythms depending on syn-
chronization with, for example, serum shock. These
intracellular daily rhythms have never been investigated
in primary material of patients with RA and osteoarthri-
tis (OA).
The circadian rhythm is generated in the superordi-
nate hypothalamic nucleus suprachiasmaticus [7], and
this rhythm can be transferred to peripheral cells of
the body by hormonal and neuronal signals [8-12].
Under physiological conditions, this was described for
hepatocytes, cardiomyocytes, peripheral blood
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mononuclear cells, natural killer cells, CD4+ T cells
and others [8-13]. After synchronization with serum
shock in vitro, rhythms of molecular clocks are often
self-sustained under constant culture conditions
[12,14,15]. This has been demonstrated for neurons of
the nucleus suprachiasmaticus [14], T cells [12] and
fibroblasts [15]. Particularly, fibroblasts demonstrated a
self-sustained rhythm with three regular periods and
stable amplitudes over 72 hours [15]. This peripheral
rhythm of fibroblasts can be modulated by systemic
factors, such as glucocorticoids [16]. It is thought that
these rhythms serve an overall coupling of important
bodily functions which is, for example, reflected in
coupling of feeding behavior and cardiomyocyte
responsiveness to ingested fatty acids [8].
Coupling phenomena can be observed on the level of
the entire body as a simultaneous up-regulation of coop-
erative hormones, such as cortisol and norepinephrine,
which both rise during the early morning hours to sup-
port release of energy-rich substrates from adipose tis-
sue and liver and both decrease at midnight kicking off
nightly immune phenomena [17]. Hormones of the
hypothalamic-pituitary adrenal (HPA) axis and the sym-
pathetic nervous system (SNS) are coupled in healthy
subjects but are uncoupled in patients with Crohn’s dis-
ease, ulcerative colitis and systemic lupus erythematosus
[18,19]. Circadian rhythms of cortisol can be altered in
patients with RA [20,21]. We recently reported that cou-
pling phenomena are important to suppress proinflam-
matory cytokines in primary synovial cells of patients
with RA [22].
It can be hypothesized that coupling of molecular
clocks that guide endogenous cellular rhythms on the
peripheral cellular level play an important role in
inflammation. Molecular clocks coordinate timely and
functionally coupled and uncoupled cellular phenomena.
Alterations of this coordination by deletion of important
molecular clocks aggravate experimental arthritis as
recently demonstrated for the first time in mice [23].
There is a regular cross-talk of molecular clocks and
TNF in fibroblasts [23]. However, rhythms of molecular
clocks have never been investigated in primary material
of RA and OA patients.
This study was initiated to examine the presence of
molecular clocks in primary tissue of OA and RA
patients. We hypothesized that density of cells positive
for molecular clocks can change during the day in these
patients in a rhythmic fashion. We further hypothesized
that typical daily rhythms of molecular clocks can be
demonstrated in the primary fibroblast of OA and RA
patients and that proinflammatory cytokines, such as IL-
1b and TNF, influence the presence and rhythm of
molecular clocks.
Materials and methods
Patients and control subjects
Synovial tissue was obtained from RA and OA patients
during knee replacement surgery as described earlier
[24]. Control synovial tissue samples were obtained
from patients with joint trauma during routine arthro-
scopy or open joint surgery for diagnostic and therapeu-
tic procedures. All patients were informed of the
purpose of the study and gave written consent. The
study was approved by the Ethics Committee of the
University of Regensburg. Characteristics of patients are
given in Table 1.
Immunofluorescence of synovial tissue
The tissue preparation for histological studies was per-
formed as previously described [24]. Cryosections (5
μm) of at least three different formaldehyde-fixed syno-
vial tissue samples from each patient/control were used.
We used primary antibodies against the clock proteins
BMAL-1 (1:100, polyclonal, rabbit versus human, Dia-
nova, Hamburg, Germany), CLOCK (1:100, polyclonal,
rabbit versus human, Calbiochem, Darmstadt, Ger-
many), Period 1 (1:100, polyclonal, rabbit versus human,
Millipore, Eschborn, Germany), Period 2 (1:100, polyclo-
nal, rabbit versus human, Biozol, Eching, Germany). The
secondary antibody was coupled to the fluorescent dye
Alexa Fluor 546 (polyclonal, goat versus rabbit, Invitro-
gen, Karlsruhe, Germany). Non-specific binding sites
were blocked with phosphate-buffered saline containing
10% fetal bovine serum, 10% bovine serum albumin, and
10% normal chicken serum or 10% normal goat serum
for 45 minutes at room temperature. The samples were
then incubated with the respective primary antibody for
3 hours at room temperature, washed and then incu-
bated with specific secondary antibody for 90 minutes.
After 4’-6-diamidino-2-phenylindole (DAPI; Roche,
Mannheim, Germany) staining, slides were covered with
fluorescence mounting medium (DAKO, Hamburg, Ger-
many) and stored at 4°C until microscopy (performed
within four days). Control staining was carried out with
the secondary antibody alone or using unspecific rabbit
serum instead of the primary antibody. Control staining
always yielded a negative result.
Synovial fibroblasts
Mixed synoviocytes were isolated from synovial tissue as
described before [24]. The cells were cultured over three
to six passages yielding a homogenous cell population of
synovial fibroblasts. In an earlier study [25], it was
demonstrated that only after seven to eight passages
more than 10% of the genes were differentially
expressed. Thus, passage 6 was used as the upper limit.
The same study also demonstrated that doubling rate
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was constant for up to five passages and decreased after
passages 6 to 8 [25]. With this information in mind, we
focused on passages 3 to 6, which was necessary due to
the enormous amount of cells needed.
Preliminary experiments did not show a difference in
molecular clock mRNA in synovial fibroblasts of passage
3 to 6. Per well, 150,000 cells were cultured in culture
medium (RPMI 1640, Sigma, Steinheim, Germany) con-
taining 10% fetal bovine serum, 1% penicillin/streptomy-
cin and 0.1% amphotericin B for 24 hours. Then, cells
were starved for 24 hours in medium without fetal
bovine serum in order to synchronize cellular rhythms
as previously reported [26]. To start daily clock rhythms,
cells received a serum shock (10% fetal bovine serum) in
culture medium described above. At time t = 0, cells
were treated without additional cytokines (control) or
with IL-1b or TNF. Starting at t = 0, cells were har-
vested every 2 hours for a period of 72 hours (this is a
high time resolution in these types of experiments).
Harvested cells were washed and stored in RNA later
solution (Sigma, Steinheim, Germany) at 4°C and then
at -30°C until RNA isolation.
MH7A synovial fibroblast cell line
Some of the experiments were repeated with the MH7A
synovial fibroblast cell line. This cell line was derived
from immortalized synovial fibroblasts of a patient with
RA using the SV40 T antigen [27]. MH7A were pur-
chased from Riken, Japan, with informed consent of
Central Research Laboratories, Kissei Pharmaceutical
Co., Ltd., Nagano, Japan. Similar as mentioned for pri-
mary synovial fibroblasts, synchronization was estab-
lished by serum shock. Cells were incubated at indicated
concentrations of IL-1b and TNF. RNA isolation was
performed as described.
RNA isolation and quantitative PCR
Since most studies on molecular clocks studied mRNA
and because protein determination with Western blot
was extremely time-consuming (preliminary studies), we
used quantitative PCR to detect levels of molecular
clock mRNA. RNA was isolated according to the manu-
facturer’s instructions (Nucleo Spin RNA II Kit,
Macherey Nagel, Düren, Germany). cDNA was con-
verted from total RNA (RevertAid First Strand cDNA
Synthesis Kit; Fermentas, St. Leon-Roth, Germany). For
quantitative PCR (qPCR), 1 μl of cDNA preparation, 1
μl of specific primer (100 pmol/μl; Eurofins MWG
Operon, Ebersberg, Germany) and Brilliant II SYBR
Green qPCR Master Mix (Agilent Technologies, Wald-
bronn, Germany) were applied in a total volume of 10
μl. The PCR reaction was evaluated by melting curve
analysis according to the manufacturer’s instructions
(Thermal Cycler 7900 HAT, Applied Biosystems, Darm-
stadt, Germany). Each quantitative PCR was performed
in triplicate.
The following primers were used: BMAL-1 forward
ATCAGACGATGAATTGAAACAC, BMAL-1 reverse
TCATTCTGGCTGTAGTTGAGGA; CLOCK forward
ACCCTTCCTCAACACCAAC, CLOCK reverse
GACTGGGAATTTATGGACTGAC; Period 1 forward
AGTTCCATTGCCTACAGCC, Period 1 reverse
GAAGTGCTGTCATGAGTTCC; Period 2 forward
GCATTTCATTAAGTGCGTCC, Period 2 reverse
GCTTCTCTCTGTCCTCCTTC; Per3 forward
GTTGTCGCCATCGTTTTTGCC, Per3 reverse
Table 1 Characteristics of patients
Osteoarthritis Rheumatoid arthritis
number 17 17
age (yr) 68.8 ± 1.6 62.1 ± 3.0
sex (f/m) 14/3 13/4
C-reactive protein (mg/l) 9.4 ± 4.1 40.1 ± 14.6*
erythrocyte sedimentation rate (mm) 12.4 ± 2.6 41.5 ± 9.2*
medication
prednisolone (%) N.A. 88.0
daily prednisolone (mg/d) N.A. 4.3 ± 0.5
methotrexate (%) N.A. 35.3
anti-TNF therapy (%) N.A. 5.9
leflunomide (%) N.A. 29.4
cyclosporin A (%) N.A. 5.9
peripherally acting opioidergic drugs (%) 41.2 35.3
Non-steroidal antiinflammatory drugs (%) 70.6 64.7
*P < 0.05 for the comparison vs. osteoarthritis. Abbreviations: N.A., not applicable.
Data are given as means ± SEM, percentages in parentheses, and ranges in brackets
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GCTTTGTGCCTCCCACTTTTCC; Cryptochrome 1
forward GGATTGATGCCATCATGACAC, Crypto-
chrome 1 reverse CCTTCATTCCTTCTTCCCAAC;
Cryptochrome 2 forward GCGCTGCGTTTA-
CATTCTC, Cryptochrome 2 reverse
CTTGTGTCCAAATCTTCCAGAG; Rev-erba forward
CCCTTCTTCCTCATCTTCCTC, Rev-erba reverse
GATGTTGCTGGTGCTCTTG.
Furthermore, Cdc2 was detected in order to estimate
the interrelation to the cell cycle because this factor is
detrimental for cell cycle progression [28]. The following
primers were used for Cdc2: forward ACTGGCT-
GATTTTGGCCTTGC, reverse AGTTGAGTAAC-
GAGCTGACCCC. The housekeeper 18s was used as
control using the following primers: forward
CGGCTACCACATCCAAGGAA, reverse GCTGGAAT-
TACCGCGGCTGC. Each gene was normalized to the
house keeper mRNA of 18s. The ratio of the mRNA of
a specific gene divided by the mRNA of 18s at t = 0 was
defined as 1.00 and ratios of every following time point
were calculated in relation to t = 0.
Statistical analyses
Medians of groups were compared by Mann-Whitney U
test and Box Plots were demonstrated to respect the
non-normal distribution of data (Sigma Plot 11.0, Systat
Software, Inc., Erkrath, Germany). For time series analy-
sis, cubic regression was used for the interrelation of
time of day and density of cells positive for molecular
clocks in synovial tissue (Sigma Plot). In addition, auto-
correlation analyses were used to identify a possible per-
iod of the rhythm (PASW Statistics, 18.0, IBM SPSS via
IBM Germany, Ehningen, Germany). We did not use a
sine or cosine wave fitting model because it was unclear
whether or not oscillations really exist. Trigonometric
wave fitting always yields a rhythm and, thus, it is not
useful to apply this technique in a situation where the
presence of oscillation is not really known. Elapsed time
between serum shock synchronization and first peak of
molecular clock mRNA curves was determined by
inspection of mRNA curves in every individual. The sig-
nificance level was P < 0.05.
Results
Clock proteins in synovial tissue
The presence of molecular clocks is a prerequisite for
endogenous cellular rhythms. This prompted us to
study protein abundance in primary material of patients
with OA, RA and trauma controls. Immunofluorescence
demonstrated ubiquitous cellular distribution of BMAL-
1, CLOCK, Period 1 and Period 2 proteins in patients
with RA and OA (Figure 1). Without variation, all cells
demonstrated these four clock proteins. In addition,
specimens of trauma controls similarly demonstrated
the four molecular clocks (data not shown).
In order to study a possible difference between OA
and RA material, cellular density of synovial cells posi-
tive for molecular clocks was investigated. While syno-
vial density of positive cells for CLOCK and Period 2
were similar between disease groups, density of BMAL-
1-positive cells was higher in RA compared to OA (Fig-
ure 2A). For Period 1-positive cells, a similar trend
existed (Figure 2A). This indicates that RA synovial tis-
sue provides an environment for increased molecular
clock levels.
Since BMAL-1 and Period 1 undulate during the day,
we hypothesized that this oscillation can be visible when
taking patient material at different operation time points
during the day. We had access to material taken
between 8:00 am and 4:00 pm of a large number of
patients with RA and OA as well as trauma controls.
Although one would have expected a difference between
morning and afternoon, no statistically significant varia-
tion of synovial density of positive cells was observed in
these patient groups (Figure 2B).
In preliminary experiments, we evaluated the use of
Western blots for further protein analyses of molecular
clocks (data not shown). However, due to the time ser-
ies with 36 time points of cell removal and lack of ade-
quate amounts of primary cells, this technique was
abandoned.
Molecular clock mRNA in synovial fibroblasts
Typically, quantitative PCR is used to study undulation
of molecular clock mRNA over three days [15], which
was also employed in the present study. After serum
shock synchronization, synovial fibroblasts start with a
huge rise of molecular clock mRNA as demonstrated in
Figure 3. The rise of mRNA is immediate for Period 1
and Period 2 and a little delayed for BMAL-1 in both
OA and RA patients (Figure 3). Using the median of
mRNA of all patients in a disease group at a single time
point, we were able to demonstrate oscillation curves
with a total of maximal four peaks (Figure 3, yellow
areas). However, time series analysis with autocorrela-
tion did not reveal a regular pattern to determine a per-
iod of oscillation in OA and RA patients (data not
shown). In other words, oscillation is masked by a low
signal-to-noise ratio in OA and RA patients.
Only in fibroblasts of healthy subjects did we find a
regular rhythm for BMAL-1 and Period 1 as demon-
strated by autocorrelation analyses (Additional file 1,
Figure S1A). These analyses revealed a period of 24
hours for both molecular clocks (Additional file 1, Fig-
ure S1A; time between red coefficients outside the con-
fidence limits).
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Influence of IL-1b and TNF on molecular clock mRNA in
synovial fibroblasts
Since time series did not reveal molecular clock mRNA
oscillation in OA and RA patients, we used the average
of all 36 time points of every patient for further ana-
lyses. IL-1b and TNF are abundant proinflammatory
cytokines found in patients with OA and RA. Thus,
these two cytokines were studied in order to investigate
the influence on molecular clock mRNA. While IL-1b
had no influence on average mRNA of BMAL-1,
CLOCK, Period 1 and Period 2 in OA synovial fibro-
blasts (Figure 4A), TNF inhibited mRNA of CLOCK,
Period 1 and Period 2 (Figure 4A). This is demonstrated
in the oscillation curve of Period 1 mRNA (compare
green line of control conditions with brown line in Fig-
ure 4B, right panel). There are no influences on the
BMAL-1 mRNA oscillation curve (Figure 4B, left panel).
Similar to OA synovial fibroblasts, fibroblasts of healthy
controls show a slight reduction of average CLOCK
mRNA by TNF (Additional file 1, Figure S1B).
Figure 1 Presence of typical clock proteins in synovial tissue. Results of patients with osteoarthritis (OA) and rheumatoid arthritis (RA) are
demonstrated. Nuclei are stained in blue with DAPI. The red staining is specific for the individual clock protein. Control staining is not given but
yielded slides with negative results (only DAPI staining of nuclei is visible). Abbreviations: BMAL-1, brain and muscle arnt-like-1; DAPI, 4’-6-
Diamidino-2-phenylindole; OA, osteoarthritis; Per, period homologue of Drosophila period; RA, rheumatoid arthritis.
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In contrast to OA synovial fibroblasts, both cytokines
stimulated average mRNA of RA synovial fibroblasts
(Figure 5A), which is exemplified by BMAL-1 and Per-
iod 1 mRNA oscillation curves (Figure 5B). The differ-
ent protein levels demonstrated in Figure 2A supports
that increased mRNA levels translates into increased
protein levels.
In order to intensify these investigations, the RA syno-
vial fibroblast cell line MH7A was used (a large number
of cells was obtained from these non-primary cells).
Both, IL-1b and TNF dose-dependently increased
mRNA of Period 1 and Period 2 (Figure 6A). This was
similar for CLOCK mRNA but was not statistically sig-
nificant for BMAL-1 mRNA (Additional file 2, Figure
S2).
In order to investigate a possible cell cycle-dependent
abundance of molecular clocks, the ubiquitous cell cycle
progression factor Cdc2 was investigated. The oscillation
curve of Cdc2 mRNA had one peak at approximately 30
hours after synchronization indicating one concerted
proliferation event (Additional file 3, Figure S3A), which
was largely different from the immediate peak of mole-
cular clocks (compare Figure 3). Thus, there seems to
be no direct interrelation between cell cycle and mole-
cular clocks because no parallel or anti-parallel rise or
fall of mRNA was observed. Interestingly, IL-1b and
TNF increased Cdc2 mRNA in RA but not in OA or
control subjects (Additional file 3, Figure S3B). In the
direct comparison of RA and OA oscillation of Cdc2
mRNA, the peak was little delayed in RA compared to
OA (Additional file 4, Figure S4, black letters).
Influence of IL-1b and TNF on molecular clock mRNA
oscillation characteristics
Proinflammatory cytokines might influence oscillation
characteristics of molecular clocks. As mentioned above,
the period of the oscillation cannot be studied due to
the rapid loss of rhythmicity (see all curves in Figure 3).
Thus, elapsed time from start of synchronization to the
first peak of the undulation curve was scrutinized. Both,
IL-1b and TNF delayed the first peak of BMAL-1
mRNA oscillation in RA synovial fibroblasts, which did
not reach the significance level in OA synovial fibro-
blasts (Figure 6B). IL-1b and TNF did not change oscil-
lation characteristics of other molecular clocks
investigated (Additional file 4, Figure S4).
Obviously, there exist four different groups of molecu-
lar clocks as determined by the elapsed time from start
to first peak (Additional file 4, Figure S4). One group
has the peak between 0 and 6 h (blue), one group
between 8 and 14 h (pink), another group between 14
and 17 h (red), and a fourth group between 18 and 19 h
(green). Molecular clocks in these different groups
reflect the different partners of the intracellular molecu-
lar clock network (Additional file 5, Figure S5). How-
ever, conditions in RA and OA synovial fibroblasts
Figure 2 Density of cells positive for typical clock proteins. A) Density of clock protein - positive cells in synovial tissue of patients with
rheumatoid arthritis (RA) and osteoarthritis (OA). *P < 0.05 vs. RA; aP < 0.10 vs. RA. B) Density of cells positive for BMAL-1 (left panel) and Period
1 (Per1, right panel) over time. Synovial tissue was obtained from healthy subjects (HS, green) and patients with OA (black) and RA (red) at
different time points during the day (time of operation start was grouped at 8:00 am, 11:00 am, 1:00 pm and 3:00 pm). Symbols in A) and B)
indicate the mean value of cellular density of 17 randomly chosen high power fields from stained tissue of one individual patient. For example,
this staining included n = 12 healthy subjects at time point 8:00 am. The correlation coefficient of cubic regression is given.
Haas and Straub Arthritis Research & Therapy 2012, 14:R122
http://arthritis-research.com/content/14/3/R122
Page 6 of 12
prevent one or two full oscillation cycles, which are visi-
ble in healthy fibroblasts (Additional file 1, Figure S1A).
Discussion
Molecular clocks play an important role in coordinating
circadian rhythms in the body and intracellular circadian
networks in peripheral cells. It is thought that the coor-
dinated network establishes coupling and uncoupling of
pathways to support cellular function in parallel and
anti-parallel fashion. To our knowledge, molecular clock
proteins have not been investigated in primary synovial
material of patients with OA and RA but similarly not
in other rheumatic diseases.
There are three reports that linked molecular clocks
to rheumatology. In mouse chondrocytes, CLOCK, Per-
iod 1 and Period 2 were found to exhibit biological
rhythms after serum shock [29]. The authors found
CLOCK upregulated after mechanical stress which iden-
tifies CLOCK as a possible mechanosensitive gene [29].
Another report demonstrated that melatonin inhibited
Cryptochrome 1 in a mouse model of experimental
arthritis [30]. However, no functional tests were per-
formed to understand the link between melatonin, cryp-
tochrome 1 and proinflammatory mechanisms [30].
In a third study, the authors investigated mice with
collagen type II-induced arthritis using synovial and
spleen cells [23]. They found marked upregulation of
Period 2 independent of the light dark cycle in arthritic
animals. This is somewhat similar to the upregulation
observed in RA patients compared to OA (Figure 2A).
In addition, they found that daily rhythm of Period 1/2
mRNA shifted six hours back and that of Bmal-1
mRNA remained constantly low indicating dampened
rhythm [23]. They further demonstrated that mice defi-
cient in Cryptochrome 1 and Cryptochrome 2 demon-
strated arthritis aggravation, which might be due to
upregulation of TNF [23]. They concluded that the lack
of Cryptochrome gene function abrogates normal
Figure 3 mRNA of selected molecular clocks over time in synovial fibroblasts. Results of patients with osteoarthritis (n = 6) and
rheumatoid arthritis (n = 7) are demonstrated. One symbol represents the median value of mRNA of synovial fibroblast cultures of all included
patients. The yellow area depicts the increase of the curve at different time points during an observation time of 72 hours. Typically mRNA starts
with a huge peak after serum shock synchronization, which soon dies down. Abbreviations see legend to Figure 1.
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Figure 4 Modulation by IL-1b and TNF of mRNA of clock proteins over time. Results from experiments with synovial fibroblasts of patients
with osteoarthritis are shown (n = 6). A) Mean of mRNA of molecular clock and influence of IL-1b (1 ng/ml) and TNF (1 ng/ml). Of every
patient, the average value of mRNA was calculated from 36 time points during an observation period of 72 hours. The Box plot is generated
from n = 6 median values of osteoarthritis patients. Box plots give the 10th, 25th, 50th (median), 75th and 90th percentiles. **P < 0.01, ##P < 0.001
vs. respective control (Co). B) mRNA of selected molecular clocks over time in synovial fibroblasts of patients with osteoarthritis (n = 6). One
symbol represents the median value of mRNA of synovial fibroblast cultures of the six patients at a given time point. The green control line is
given for comparison (see Figure 3). Abbreviations see legend to Figure 1.
Figure 5 Modulation by IL-1b and TNF of mRNA of clock proteins over time. Results of experiments with synovial fibroblasts of patients
with rheumatoid arthritis are shown (n = 7). A) Mean of mRNA of molecular clock and influence of IL-1b (1 ng/ml) and TNF (1 ng/ml). Of every
patient, the average value of mRNA was calculated from 36 time points during an observation period of 72 hours. The Box plot is generated
from n = 7 median values of rheumatoid arthritis patients. Box plots give the 10th, 25th, 50th (median), 75th and 90th percentiles. *P < 0.05, **P <
0.01, #P < 0.005, ##P < 0.001 vs. respective control (Co). B) mRNA of selected molecular clocks over time in synovial fibroblasts of patients with
rheumatoid arthritis (n = 7). One symbol represents the median value of mRNA of synovial fibroblast cultures of the seven patients at a given
time point. The green control line is given for comparison (see Figure 3). Abbreviations see legend to Figure 1.
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biological clock function and aggravates pathological
changes in arthritis.
Our report adds more information on human subjects
with OA and RA. All clock proteins are ubiquitously
present in synovial cells of these patients and in trauma
controls (all cells are positive). It seems that density of
molecular clock-positive cells was higher in RA com-
pared to OA, which was significant for BMAL-1. Since
we have not corrected for overall cellular density, this
difference might depend on increased cellular infiltration
in RA compared to OA though density is relatively simi-
lar in the chronic phase of both diseases. In addition, a
possible undulation of density of molecular clock-posi-
tive cells did not exist in synovial tissue. This might
depend on several mechanisms, such as heterogeneous
chronotypes of investigated patients (two chronotypes
are known: lark and owl), different medication in the
various patients that might influence molecular clock
levels, short observation period from 8:00 am to 4:00
pm, and low numbers of investigated patients (type II
error). Since several studies demonstrated that inflam-
mation disturbs molecular clock oscillation in different
cell types in vivo and in vitro [31-36], it might well be
that typical oscillations are abrogated in inflamed tissue
in OA and RA.
A closer investigation of molecular clock mRNA
demonstrated that synovial fibroblasts of OA and RA
patients are capable of starting the typical oscillation.
However, a long-standing rhythm was not established
because the signal rapidly died down. Time series analy-
sis did not demonstrate regularity in OA and RA but in
healthy fibroblasts. This can depend on the contact to
the proinflammatory environment to which these cells
have been adapted prior to serum shock synchronization
in OA and RA [31-36].
When comparing the hardly visible oscillation in these
synovial fibroblasts of OA and RA patients, fibroblasts
of normal rats demonstrate excellent rhythmic oscilla-
tion [15]. From this first study in rat fibroblasts, this cell
type was one of the typical peripheral cell types to study
daily rhythms of the intracellular molecular clock net-
work [37-40]. This is also true for normal human fibro-
blasts of the skin [40], and we also found a rhythm in
fibroblasts of healthy individuals. Thus, one would have
expected similar rhythms in OA and RA fibroblasts. The
question appears whether or not proinflammatory fac-
tors can influence molecular clock mRNA.
Our study demonstrated that proinflammatory cyto-
kines decreased or tended to decrease mRNA of mole-
cular clocks in OA synovial fibroblasts. This was
Figure 6 Modulation by IL-1b and TNF of clock proteins in synovial fibroblasts. Abbreviations see legend to Figure 1. Box plots give the
10th, 25th, 50th (median), 75th and 90th percentiles. A) Mean of mRNA of Period 1 and Period 2 and dose-dependent influence of IL-1b and TNF
(both ng/ml) on MH7A synovial fibroblasts. Effects on CLOCK and BMAL-1 are demonstrated in Additional file 2 Figure S2. The Box Plots are
generated from at least 12 independent experiments over 36 hours (n = 19 for IL-1b; n = 12 for TNF). *P < 0.05, #P < 0.005, ##P < 0.001 vs.
highest concentration. B) Influence of IL-1b and TNF (both 1 ng/ml) on elapsed time to first BMAL-1 mRNA peak after synchronization. Every
symbol represents the time to first peak of one patient during 72 hours of observation (sample interval two hours). *P < 0.05, ##P < 0.001 vs.
control (Co).
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opposite in RA synovial fibroblast which might also
explain the higher density of molecular clock - positive
cells in RA synovial tissue. In these experiments, we
used a dose of 1 ng/ml of IL-1b or TNF. Although this
is a typical cytokine concentration to stimulate cells in
vitro, it does not give us a dose-response effect and it is
difficult to simply translate it to a situation in vivo.
Nevertheless, these concentrations appear in the proxi-
mity of cytokine-producing cells. In order to study the
subject more carefully, we applied different doses in the
MH7A RA synovial fibroblast cell line. Here a clear
dose-response was observable.
In addition, IL-1b and TNF both changed the time
point of the first BMAL-1 mRNA peak by induction of
a delay of approximately three to six hours. Similar
shifts of molecular clock peaks have been demonstrated
in a model of experimental arthritis [23], which indi-
cates that inflammation can directly interfere with
rhythmicity of cells. This is supported by a TNF-induced
inhibition of Period 1 to 3 in NIH 3T3 fibroblasts and in
mice which depends on a direct influence of BMAL-1
and CLOCK binding to the E-box [36]. In addition,
expression of molecular clock genes was markedly
inhibited in peripheral blood leukocytes in surgical ICU
patients [41].
In further time series analyses, according to the first
peak of mRNA rhythm, four different groups of molecu-
lar clocks were identified. Period 1, Period 2, Period 3,
cryptochrome 1 and cryptochrome 2 (blue in Additional
files 4 and 5, Figures S4 and S5) demonstrated the first
peak immediately after the serum shock. BMAL-1 and
CLOCK demonstrated an intermediate pattern with a
peak at 8 to 17 hours (pink and red in Additional files 4
and 5, Figures S4 and S5). Furthermore, the peak of
Rev-Erba mRNA appeared late between 18 and 19
hours (green in Additional files 4 and 5, Figures S4 and
S5). This sequential increase of mRNA peaks is indica-
tive of a first successful attempt to start oscillation in
these OA and RA synovial fibroblasts. However, this
phenomenon is impermanent, leading to rapid destruc-
tion of the rhythm.
Conclusions
These experiments with primary synovial tissue and
fibroblasts did not demonstrate the expected oscillation
of molecular clock protein or mRNA. Since proinflam-
matory cytokines can change the level of mRNA and
time interval to peak mRNA, the proinflammatory envir-
onment most probably destroys the regular rhythm.
Since synovial fibroblasts were derived from chronically
inflamed tissue, molecular clock alterations are most
probably programmed for a longer period of time. Dis-
ruption of coupled intracellular pathways might be a
proinflammatory event.
Additional material
Additional file 1: Autocorrelation of clock factors and modulation
by IL-1b and TNF of mRNA expression of clock proteins over time
in synovial fibroblasts from healthy subjects. A) Autocorrelation
coefficient of selected clock factors. Autocorrelation is used to show a
period of oscillation. mRNA expression levels of BMAL-1 and Per1 at 36
separate time points over 72 hours were used to generate
autocorrelation diagrams. Every bar represents an autocorrelation
coefficient generated by moving the data with the given lag number.
The red lines in the graph give the 95% confidence interval of the
correlation coefficients. Only red coefficients outside the red lines are
significant. B) Mean of mRNA expression of clock factor and influence of
IL-1b (1 ng/ml) and TNF (1 ng/ml). Of every person, the average value of
mRNA expression was calculated from 36 time points during an
observation period of 72 hours. The Box plot is generated from n = 4
median values of healthy subjects. Box plots give the 10th, 25th, 50th
(median), 75th and 90th percentiles. ##P < 0.001 vs. respective control
(Co). Abbreviations see legend to Figure 1.
Additional file 2: Modulation by IL-1b and TNF of clock proteins in
synovial fibroblasts. Abbreviations see legend to Figure 1. Mean of
mRNA expression of BMAL-1 and CLOCK and dose-dependent influence
of IL-1b and TNF (both ng/ml) on MH7A synovial fibroblasts. The Box
Plots are generated from at least 12 independent experiments over 36
hours (n = 19 for IL-1b; n = 12 for TNF). Box plots give the 10th, 25th, 50th
(median), 75th and 90th percentiles. *P < 0.05, **P < 0.01, #P < 0.005 vs.
highest concentration.
Additional file 3: Modulation by IL-1b and TNF of mRNA expression
of the cell cycle factor Cdc2 over time in synovial fibroblasts of
patients with rheumatoid arthritis (RA, n = 7), osteoarthritis (OA, n =
6), and healthy subjects (HS, n = 4). Abbreviations see legend to Figure 1.
A) mRNA expression of Cdc2 over time in fibroblasts of patients with RA
and OA, and HS. The lines are generated using the median value of mRNA
expression of synovial fibroblast cultures at 36 time points during 72 hours.
B) Average of mRNA expression of clock factor and influence of IL-1b (1 ng/
ml) and TNF (1 ng/ml). Of every subject, the average value of mRNA
expression was calculated from 36 time points during an observation
period of 72 hours. The Box plot is generated from values of patients with
RA and OA, and HS. Box plots give the 10th, 25th, 50th (median), 75th and
90th percentiles. *P < 0.05, ##P < 0.001 vs. respective control (Co).
Additional file 4: First peak after cell synchronization of individual
clock factor mRNAs in OA (n = 6) and RA (n = 7) with and without
additional 1 ng IL-1b/ml. Different colors indicate co-regulated factors
according to Additional file 5, Figure S5. *P < 0.05 vs. OA Cdc2+IL-1b; #P
< 0.005 vs. OA Cdc2; ##P < 0.001 vs. RA BMAl-1 without IL-1b; §Cdc2 is
not a clock factor but a cell cycle progression factor which indicates the
cell cyle progression and, thus, proliferation. Abbreviations: BMAL-1, brain
and muscle ARNT-like 1; Crypt, cryptochrome; OA, osteoarthritis; Per,
period homologue of Drosophila period; RA, rheumatoid arthritis; rev-
erba, V-erbA-related protein 1-related; sync, synchronization.
Additional file 5: Regulation of the circadian rhythm of clock
proteins. The interwoven pathways are given: 1st pathway: CLOCK (C),
BMAL-1(B), Period 1 to 3 (Per1, 2, 3), and Cryptochrome 1+2 (Cry1, 2); 2nd
pathway: Rev-Erba, BMAL-1. CLOCK and BMAL 1 dimerize and bind to E-
boxes in the promotor region of Period (Per) genes, cryptochrome (Cry)
genes, Rev-Erba, and BMAL-1 activating their transcription. The
corresponding proteins accumulate in the cytoplasm, translocate to the
nucleus, and inhibit binding of CLOCK and BMAL-1 to the E-Boxes. This
inhibition leads to a down-regulation of transcription of these genes. A
very similar loop exists with respect to Rev-Erba and BMAL-1 regulation.
The degradation process via ubiquitination and SUMOylation leads to the
know 24 hour cycle.
Abbreviations
DAPI: 4’-6-diamidino-2-phenylindole; HPA: hypothalamic-pituitary-adrenal; IL:
interleukin; OA: osteoarthritis; RA: rheumatoid arthritis; SF: synovial fibroblasts;
SNS: sympathetic nervous system; TNF: tumor necrosis factor.
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